Company registration number 13832318 (England and Wales)
SALFORD AND TRAFFORD LOCAL MEDICAL COMMITTEE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2022
PAGES FOR FILING WITH REGISTRAR
SALFORD AND TRAFFORD LOCAL MEDICAL COMMITTEE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
SALFORD AND TRAFFORD LOCAL MEDICAL COMMITTEE LIMITED
BALANCE SHEET
AS AT 31 MARCH 2022
31 March 2022
- 1 -
2022
Notes
£
£
Reserves
3
-

The directors of the company have elected not to include a copy of the income and expenditure account within the financial statements.true

For the financial period ended 31 March 2022 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 17 October 2023 and are signed on its behalf by:
E  Mannerings
Director
Company Registration No. 13832318
SALFORD AND TRAFFORD LOCAL MEDICAL COMMITTEE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2022
- 2 -
1
Accounting policies
Company information

Salford and Trafford Local Medical Committee Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is 17 Alvaston Business Park, Middlewich Rd, Nantwich, CW5 6PF.

1.1
Reporting period

The financial statements cover the period from incorporation to 31 March 2022, during which time the company was dormant.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Profit and loss account

The company has not traded during the period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2022
Number
Total
3
3
Members' liability

The company is limited by guarantee, not having a share capital and consequently the liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the company on winding up such amounts as may be required not exceeding £1.

2022-03-312022-01-06true17 October 2023CCH SoftwareCCH Accounts Production 2023.100No description of principal activityE ManneringsA PrabhakaranJ Walton138323182022-01-062022-03-31138323182022-03-3113832318bus:Director12022-01-062022-03-3113832318bus:EntityHasNeverTraded2022-01-062022-03-3113832318bus:CompanyLimitedByGuarantee2022-01-062022-03-3113832318bus:SmallCompaniesRegimeForAccounts2022-01-062022-03-3113832318bus:FRS1022022-01-062022-03-3113832318bus:AuditExemptWithAccountantsReport2022-01-062022-03-3113832318bus:Director22022-01-062022-03-3113832318bus:Director32022-01-062022-03-3113832318bus:FullAccounts2022-01-062022-03-31xbrli:purexbrli:shares